diabetes drugs market

Diabetes Drugs Market: US Analysis, Share, Trends, Application Analysis And Forecast To 2028

  • Published Date: 2022-12-26
  • Report ID: 138096
  • Pages: 200
  • Format: prudent report format

Report Overview

The U.S. Diabetes market size stood at USD 10 billion 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The significant growth in the market can be attributed to factors, such as the rising prevalence of diabetes and increasing number of programs initiated by various health organizations related to health awareness. North America holds a major market share as of 2019, followed by Asia-pacific region. The increase in number of diabetes patients is mainly due to increasing obesity among people caused by unhealthy diets and sedentary lifestyles. Based on drugs, the Insulin holds a significant share in the market.



Market Drivers

Rising awareness about preventive care and technological advancement are among the factors expected to boost market growth.
Rising healthcare funding by government and private institutions in the field of diabetes care are contributing to constant improvement in novel diabetes management solutions.




  1. U.S. Diabetes Drugs Market Overview.........................

    1. Market Size



  2. Market Growth Drivers...

    1. Rise in U.S. Prevalence of Diabetes Mellitus

    2. Growing R&D Investments and Reimbursement Policies



  3. Market Growth Restraints..

    1. Rising Cost of Drugs

    2. Strict Regulatory Rules

    3. Long Approval Time



  4. Diabetes Market Segmentation.............................

    1. Drug Class

      1. Insulin

      2. DPP-4 Inhibitors

      3. GLP-1 Receptor Agonists

      4. SGLT2 Inhibitors

      5. Others



    2. Route of Administration

      1. Oral

      2. Intravenous

      3. Subcutaneous





  5. Diabetes Major Drugs Market Share...

    1. Market Analysis, Insights and Forecast By Drug Type and Revenue



  6. Competitive Landscape.....

    1. Major Players

    2. Products in Pipeline



  7. Key Company Profiles.....

    1. Novo Nordisk Company overview, Product & Services, Strategies & Financials

    2. Sanofi Company overview, Product & Services, Strategies & Financials

    3. AstraZeneca Company, Product & Services, Strategies & Financials



  8. Healthcare Policies and Regulatory Landscape.....

    1. Policy changes and Reimbursement scenario



  9. Factors Driving Future Growth

    1. New Trends and Development of Cardiovascular drug market

    2. Future Opportunities



  10. Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.